RT Journal Article
SR Electronic
T1 1056 XTX301, a tumor activated, half-life extended IL-12 promoted potent anti-tumor immunity and activity across multiple syngeneic tumor models
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1163
OP A1163
DO 10.1136/jitc-2023-SITC2023.1056
VO 11
IS Suppl 1
A1 Malkova, Natalia V
A1 Patel, Ekta
A1 Vu, Sallyann
A1 Fantini, Damiano
A1 Fanny, Manoussa
A1 Guzman, Wilson
A1 Hsiao, Stephanie
A1 Johnson, Parker
A1 Yerov, Oleg
A1 Jenkins, Kurt
A1 Madala, Hanumantha Rao
A1 O’Toole, Caitlin
A1 Taylor, Jake
A1 Pederzoli-Ribeil, Magali
A1 Eryilmaz, Ertan
A1 Nicholson, Benjamin
A1 Bialucha, Uli
A1 O’Neil, Jennifer
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A1163.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.